PubMed Journals Articles About "Antacid" RSS

21:56 EST 16th December 2018 | BioPortfolio

Antacid PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Antacid articles that have been published worldwide.

More Information about "Antacid" on BioPortfolio

We have published hundreds of Antacid news stories on BioPortfolio along with dozens of Antacid Clinical Trials and PubMed Articles about Antacid for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Antacid Companies in our database. You can also find out about relevant Antacid Drugs and Medications on this site too.

Showing "Antacid" PubMed Articles, all 3

Meta-Analysis of Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis.

The relationship between gastroesophageal reflux disease (GERD) and idiopathic pulmonary fibrosis (IPF) is controversial. Current guidelines recommend that clinicians use regular antacid treatment, while 2 recent meta-analyses of antacid therapy in IPF were inconclusive. Our objective was to examine the evidence regarding the association between GERD and IPF through a systematic review and a meta-analysis, with special reference to the methodological quality of the observational studies.

Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Uncertainties and Controversies.

The mechanisms of idiopathic pulmonary fibrosis (IPF), a rare, devastating disease with a median survival of 3-5 years, are not fully understood. Gastroesophageal reflux disease (GERD) is a frequent comorbidity encountered in IPF. Hypothetically, GERD-associated microaspiration may lead to persistent inflammation impairing lung infrastructure, thereby possibly accelerating the progression of IPF. IPF may increase intrathoracic pressure, which can aggravate GERD and vice versa. On the basis of the possible b...

Refractory GERD, beyond proton pump inhibitors.

Pharmacologic therapy, surgery, minimally invasive therapies, and alternative therapies are different options available for the management of refractory GERD. The choice may depend on the cause of refractoriness. Increased gastric acid suppression therapy might be useful in the rare patients with persistent elevated esophageal acid exposure on proton pump inhibitors (PPI). Potassium-competitive acid blockers (P-CAB) might induce a more important acid inhibition than PPI. Baclofen might act as a reflux inhib...

Quick Search